NEWS
Post-pandemic year marked by fragile supply chains and shortages of some medicine
Looking back on 2022, Rasa Tarvydienė, the Head of Norameda's OTC Division, notes that it has been an exceptional year for the European pharmaceutical market. The biggest challenge was fragile supply chains and shortages of certain medicines due to a lack of...
Head of the Norameda Special Care Medicine Department, “Fighting for life takes the longest”
At the start of 2023, we take some time to review the past year and draw the line into the future. Sandra Ivanauskienė, founder and leader of the Norameda Special Care Medicine Department, took the time to share some insights. "Special Care Medicine Department...
Norameda in Estonia. War in Ukraine has put us in a different dimension
Reflecting on the year passing, the Head of Norameda's branch in Estonia, Edit Pung, welcomes the return to normality after the last two pandemic years. And for Norameda, there is an expected 8% growth. "We monitor growth in some areas, especially in asthma and...
Norameda in Latvia: stable growth from year to year despite crises affecting Europe
"It has been a great year marked by high sales; we managed to achieve our strategic goals. As a result, I expect around 20% growth by the end of the financial year," says Ervins Groms, leading the Norameda branch in Latvia. The oncology line was the main contributor...